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We present a case of a 58 years old man with a large heterogeneous and well circumscribed soft tissue
mass arising from the right pleural surface, found at a computer tomography of his chest. This mass after
complete resection through a right lateral open thoracotomy, proved to be a Solitary Fibrous Tumor,
previously known as ‘benign mesothelioma’. This tumor is usually discovered at routine chest X-rays
since patients are either asymptomatic or report atypical symptoms. Only 10e20% of the published cases
report a malignant solitary ﬁbrous tumor, however, deﬁnite diagnosis can only be made after complete
resection which is the proposed diagnostic algorithm for these cases.
© 2015 The Authors. Published by Elsevier Ltd. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Solitary Fibrous Tumor of the Pleura (SFTP) is a pleural neoplasm
initially thought to be of ﬁbroblastic origin and historically named
‘benign mesothelioma, localized mesothelioma or submesothelial
ﬁbroma’ [1]. SFTP is rare and accounts for less than 5% of the pri-
mary pleural tumors [2] and patients have a mean age of
58e66 years at the time of diagnosis according to large retro-
spective studies [3,4]. While approximately one third of the pa-
tients are asymptomatic, the majority report atypical symptoms
like cough, shortness of breath or chest pain at presentation [3,4].
We present a case of a male patient who underwent a right lateral
open thoracotomy for total resection of the pleural tumor which
proved to be a SFTP by the histopathological and immunochemical
examination.
2. Case report
A 58 years old Caucasian male appeared at the outpatient clinic
complaining for dull aching right sided chest pain, moderate dys-
pnea on exertion over the last 2 weeks and dry chronic cough. His
past medical history was unremarkable, apart from being a heavy
smoker for more than 30 years. The clinical examination revealed
decreased auscultatory sounds and dull note over the middle and
lower right hemithorax, while electrocardiography, transthoracic
echocardiogram and routine blood laboratory results were alloulos).
Ltd. This is an open access article unormal. Because of a rounded mass appearing at the lower right
side of his chest radiograph (Fig. 1A), the patient underwent a chest
CT scan. The CT scan displayed a large right-sided heterogeneous
but well circumscribed soft tissue mass arising from the pleural
surface, which contained central areas of low density, with absence
of local invasion (no chest wall or heart inﬁltration) (Fig. 1B).
Diagnosis was obtained by a transthoracic cutting needle biopsy,
and conﬁrmatory diagnosis was made with the pathological ex-
amination of the specimenwhich was completely resected during a
right lateral open thoracotomy (Fig. 2A). Histopathological exami-
nation of the mass (Fig. 2B) demonstrate hypocellular and hyper-
cellular areas simultaneously, separated by ﬁbrous stroma;
hypercellular areas were composed of bland spindle-cells arranged
in short fascicules. Immunohistochemical staining showed that the
tumor cells were strongly positive for CD34 (Fig. 3), bcl-2 and
vimentin which conﬁrmed the diagnosis of SFTP.3. Discussion
SFTP is a rare localized mesenchymal tumor which was initially
thought to be a mesothelial pleural lesion; nowadays, is acceptable
that it can originate from visceral organs (thyroid, lungs, etc) or
mesothelial tissues (pericardium, peritoneum, pleura) [5].
Patients may be asymptomatic and SFTP is usually discovered on
routine chest X-rays; other patients report atypical pulmonary
symptoms like dry cough, chest pain and shortness of breath [6].
Interestingly, Pierre-Marie-Bamberg (hypertrophic pulmonary
osteoarthropathy) and Doege-Potter (refractory hypoglycemia)
syndromes have been also reported in patients with SFTP [5,7].nder the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Fig. 1. A. is the chest-X-ray, B. the CT scan of the thorax.
Fig. 2. A. the picture during the operation, B. the picture of the mass with the ruler.
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mass heterogenous in attenuation, next to the chest wall or within
a ﬁssure, creating a characteristic obtuse angle with the surface [7].
Since benign and malignant SFTPs share the same radiological
appearance and transthoracic needle biopsy has poor diagnostic
value [8], their preoperative distinction is difﬁcult and not
encouraged. Therefore, complete resection of the tumor is the
standard surgical approach to conﬁrm the diagnosis.
Macroscopically, the tumor is whorled, encapsulated and
lobular, and may vary in size and weight [7,9] (in our current casethe encapsulated mass was measured 13  8  2.5 cm with a
weight of 480gr). The majority of these tumors are benign, but
malignant histological aspects like inﬁltration of adjacent struc-
tures, presence of necrosis or hemorrhage, high mitotic index and
nuclear atypia can be found [8]. Large SFTPs have been associated
with intralesional calciﬁcations and high likelihood for malignancy
[7]. Immunochemistry is quite characteristic for SFTPs since these
tumors are positive for CD34-, CD99-, bcl-2- and vimentin, but
negative for cytokeratin [5,6].
SFTPs can recur locally and distant metastases can occur
particularly in tumors that have histologic features of malignancy,
therefore close follow-up is essential [9]. Approximately 10%e20%
of the cases reported in literature are malignant [5]. Typically,
resection of the tumor is correlated with favorable outcome and
patients have a 5-year disease-free survival rate of 84% [10]. How-
ever, if the tumor cannot be removed surgically or whenmetastases
develop, chemotherapy and/or local radiotherapy have been pro-
posed as palliative care [7].
Fig. 3. The laboratory picture of the immunohistochemical staining.
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Solitary ﬁbrous tumor of the pleura is a rare localized mesen-
chymal tumor which is often radiologically and clinically mis-
diagnosed as primary lung carcinoma. However, it can be benign or
malignant and differential diagnosis is only feasible after complete
resection of this tumor which is the standard approach in these
cases. Immunochemistry of the resected tissue is an important
complementary tool for verifying the diagnosis of SFTP. Despite
that the majority of SFTPs are benign and resection maintain good
prognosis with a high 5-year survival rate, patients must beregularly followed-up since some have malignant histologic fea-
tures and local recurrences or metastatic lesions can be found.Contributors
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